Th17 cells in multiple sclerosis express higher levels of JAK2, which increases their surface expression of IFN-γR2

Journal of Immunology

Volumn 188, Issue 3, 2012, Pages 1011-1018

  Conti, Laura ^a,b   De Palma, Raffaele ^c   Rolla, Simona ^a,b   Boselli, Daniela ^a,b   Rodolico, Gabriella ^c   Kaur, Surinder ^d   Silvennoinen, Olli ^d   Niccolai, Elena ^e   Amedei, Amedeo ^e   Ivaldi, Federico ^f   Clerico, Marinella ^g   Contessa, Giulia ^g   Uccelli, Antonio ^f   Durelli, Luca ^g   Novelli, Francesco ^a,b  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d UNIVERSITY OF TAMPERE   (Finland)

^e UNIVERSITY OF FLORENCE   (Italy)

^f UNIVERSITY OF GENOA   (Italy)

^g UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; GAMMA INTERFERON RECEPTOR 2; JANUS KINASE 2; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; BIOACCUMULATION; CELL CLONE; CELL POLARITY; CELL STIMULATION; CELL SURFACE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME DEFICIENCY; HUMAN; HUMAN CELL; IMMUNOMODULATION; INTERNALIZATION; LYMPHOCYTE PROLIFERATION; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TH17 CELL;

CASE-CONTROL STUDIES; CELL PROLIFERATION; HUMANS; INTERFERONS; JANUS KINASE 2; MULTIPLE SCLEROSIS; RECEPTORS, INTERFERON; RNA, MESSENGER; TH17 CELLS;

EID: 84856566853     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1004013     Document Type: Article

References (24)

1. Durelli, L., L. Conti, M. Clerico, D. Boselli, G. Contessa, P. Ripellino, B. Ferrero, P. Eid, and F. Novelli. 2009. T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta. Ann. Neurol. 65: 499-509.
2. Bettelli, E., M. Oukka, and V. K. Kuchroo. 2007. T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8: 345-350. (Pubitemid 46745409)
3. Axtell, R. C., B. A. de Jong, K. Boniface, L. F. van der Voort, R. Bhat, P. De Sarno, R. Naves, M. Han, F. Zhong, J. G. Castellanos, et al. 2010. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat. Med. 16: 406-412.
4. Regis, G., L. Conti, D. Boselli, and F. Novelli. 2006. IFNgammaR2 trafficking tunes IFNgamma-STAT1 signaling in T lymphocytes. Trends Immunol. 27: 96-101. (Pubitemid 43221976)
5. McDonald,W. I., A. Compston, G. Edan, D. Goodkin, H. P. Hartung, F. D. Lublin, H. F. McFarland, D. W. Paty, C. H. Polman, S. C. Reingold, et al. 2001. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50: 121-127.
6. Durelli, L., E. Verdun, P. Barbero, M. Bergui, E. Versino, A. Ghezzi, E. Montanari, and M. Zaffaroni; Independent Comparison of Interferon (INCOMIN) Trial Study Group. 2002. Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN). Lancet 359: 1453-1460. (Pubitemid 34457761)
7. Amedei, A., C. Romagnani, M. Benagiano, A. Azzurri, F. Fomia, F. Torrente, A. Plebani, M. M. D'Elios, and G. Del Prete. 2001. Preferential Th1 profile of T helper cell responses in X-linked (Bruton's) agammaglobulinemia. Eur. J. Immunol. 31: 1927-1934. (Pubitemid 32547354)
8. Novelli, F., M. M. D'Elios, P. Bernabei, L. Ozmen, L. Rigamonti, F. Almerigogna, G. Forni, and G. Del Prete. 1997. Expression and role in apoptosis of the alpha- and beta-chains of the IFN-gamma receptor on human Th1 and Th2 clones. J. Immunol. 159: 206-213. (Pubitemid 127493702)
9. Bernabei, P., M. Bosticardo, G. Losana, G. Regis, F. Di Paola, S. De Angelis, M. Giovarelli, and F. Novelli. 2003. IGF-1 down-regulates IFN-gamma R2 chain surface expression and desensitizes IFN-gamma/STAT-1 signaling in human T lymphocytes. Blood 102: 2933-2939. (Pubitemid 37248867)
10. Kohlhuber, F., N. C. Rogers, D. Watling, J. Feng, D. Guschin, J. Briscoe, B. A. Witthuhn, S. V. Kotenko, S. Pestka, G. R. Stark, et al. 1997. A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses. Mol. Cell. Biol. 17: 695-706. (Pubitemid 27044369)
11. Cosmi, L., R. De Palma, V. Santarlasci, L. Maggi, M. Capone, F. Frosali, G. Rodolico, V. Querci, G. Abbate, R. Angeli, et al. 2008. Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J. Exp. Med. 205: 1903-1916.
12. Conti, L., G. Regis, A. Longo, P. Bernabei, R. Chiarle, M. Giovarelli, and F. Novelli. 2007. In the absence of IGF-1 signaling, IFN-gamma suppresses human malignant T-cell growth. Blood 109: 2496-2504. (Pubitemid 46425894)
13. Ragimbeau, J., E. Dondi, A. Alcover, P. Eid, G. Uzé, and S. Pellegrini. 2003. The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression. EMBO J. 22: 537-547. (Pubitemid 36193598)
14. Radtke, S., H. M. Hermanns, C. Haan, H. Schmitz-Van De Leur, H. Gascan, P. C. Heinrich, and I. Behrmann. 2002. Novel role of Janus kinase 1 in the regulation of oncostatin M receptor surface expression. J. Biol. Chem. 277: 11297-11305. (Pubitemid 34952894)
15. Loesch, K., L. Deng, J. W. Cowan, X. Wang, K. He, J. Jiang, R. A. Black, and S. J. Frank. 2006. Janus kinase 2 influences growth hormone receptor metalloproteolysis. Endocrinology 147: 2839-2849. (Pubitemid 43764620)
16. He, K., K. Loesch, J. W. Cowan, X. Li, L. Deng, X. Wang, J. Jiang, and S. J. Frank. 2005. Janus kinase 2 enhances the stability of the mature growth hormone receptor. Endocrinology 146: 4755-4765. (Pubitemid 41446613)
17. Martinez-Moczygemba, M., D. P. Huston, and J. T. Lei. 2007. JAK kinases control IL-5 receptor ubiquitination, degradation, and internalization. J. Leukoc. Biol. 81: 1137-1148. (Pubitemid 46495663)
18. Pestka, S., S. V. Kotenko, G. Muthukumaran, L. S. Izotova, J. R. Cook, and G. Garotta. 1997. The interferon gamma (IFN-gamma) receptor: a paradigm for the multichain cytokine receptor. Cytokine Growth Factor Rev. 8: 189-206. (Pubitemid 28077927)
19. Rigamonti, L., S. Ariotti, G. Losana, R. Gradini, M. A. Russo, E. Jouanguy, J. L. Casanova, G. Forni, and F. Novelli. 2000. Surface expression of the IFN-gamma R2 chain is regulated by intracellular trafficking in human T lymphocytes. J. Immunol. 164: 201-207. (Pubitemid 30012991)
20. Bach, E. A., S. J. Szabo, A. S. Dighe, A. Ashkenazi, M. Aguet, K. M. Murphy, and R. D. Schreiber. 1995. Ligand-induced autoregulation of IFN-gamma receptor beta chain expression in T helper cell subsets. Science 270: 1215-1218.
21. Huang, L. J., S. N. Constantinescu, and H. F. Lodish. 2001. The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor. Mol. Cell 8: 1327-1338. (Pubitemid 34085003)
22. Singh, A. V., and P. Zamboni. 2009. Anomalous venous blood flow and iron deposition in multiple sclerosis. J. Cereb. Blood Flow Metab. 29: 1867-1878.
23. Pedchenko, T. V., and S. M. LeVine. 1998. Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice. J. Neuroimmunol. 84: 188-197. (Pubitemid 28248405)
24. O'Connor, W., Jr., M. Kamanaka, C. J. Booth, T. Town, S. Nakae, Y. Iwakura, J. K. Kolls, and R. A. Flavell. 2009. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat. Immunol. 10: 603-609.